Status:
UNKNOWN
Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Severe Sepsis and Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Severe sepsis and sepsis shock are common in emergency department, with a high mortality rate. The potential severity of this disease impose a diagnosis as early as possible to start antibiotic therap...
Detailed Description
Severe sepsis and sepsis shock are common in emergency department, with a high mortality rate. The potential severity of this disease impose a diagnosis as early as possible to start antibiotic therap...
Eligibility Criteria
Inclusion
- Age\> 18 years
- Presence of at least two SIRS criteria (T °\> 38.3 ° or \<36 °, tachycardia\> 90 / min, tachypnea\> 20 / min, recent alteration of consciousness)
- Suspected Infection
- Indication of an arterial lactate assay on medical advice
- Affiliation to social security
- Informed Consent
Exclusion
- Renal dialysis
- Scalable neoplasia chemotherapy
- Patient Palliative Care
- Private Patient freedom or under legal protection
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02300415
Start Date
December 1 2014
End Date
December 1 2016
Last Update
March 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000